FrancophonIA/ELRC3.0 huggingface dataset:
English: Certain severe adverse reactions (e.g. headache, flushing, chills, myalgia, wheezing, tachycardia, lower back pain, nausea, and hypotension) may be related to the rate of infusion.
Slovenian: Določeni hudi neželeni učinki (npr. glavobol, vročinski oblivi, mrzlica, mialgija, piskajoče dihanje, tahikardija, bolečina v križu, navzea in hipotenzija) so lahko povezani s hitrostjo infundiranja.
English: The recommended dose is 0.2-0.4 g/kg every three to four weeks.
Slovenian: Priporočeni odmerek je 0,2-0,4 g/kg vsake tri do štiri tedne.
English: • If dilution to lower concentrations is required prior to infusion, KIOVIG may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin).
Slovenian: • Če je pred infundiranjem potrebno redčenje na manjše koncentracije, lahko zdravilo KIOVIG redčite s 5 % raztopino glukoze do končne koncentracije 50 mg/ml (5 % imunoglobulina).
English: Human normal immunoglobulin should be infused intravenously at an initial rate of 0.5 ml/kg BW/hr for 30 minutes.
Slovenian: Humani polispecifični imunoglobulin infundirajte intravensko z začetno hitrostjo 0,5 ml/kg TM na uro v času 30 minut.
English: You may have to wait for up to 1 year after receiving immunoglobulins before you receive your measles vaccine.
Slovenian: Po prejemu imunoglobulinov boste mogoče morali počakati do 1 leto, preden lahko prejmete cepivo proti ošpicam.
English: 2 g/kg in one dose in association with acetylsalicylic acid
Slovenian: Kawasakijev sindrom2 g/kg en odmerek, ob sočasnem zdravljenju z acetilsalicilno kislino
English: Cases of Transfusion Related Acute Lung Injury (TRALI).
Slovenian: Primeri s transfuzijo povezane akutne poškodbe pljuč (Transfusion Related Acute Lung InjuryTRALI).
English: The in-use stability of KIOVIG after dilution with a 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin) has been demonstrated for 21 days at 2°C to 8°C as well as at 28°C to 30°C; however, these studies did not include the microbial contamination and safety aspects.
Slovenian: Dokazali so, da je po redčenju s 5 % raztopino glukoze do končne koncentracije 50 mg/ml (5 % imunoglobulina) zdravilo KIOVIG med uporabo stabilno 21 dni pri temperaturi od 2°C do 8°C, pa tudi pri temperaturi od 28°C do 30°C, vendar v teh študijah niso upoštevali mikrobne kontaminacije in varnostnega vidika.
English: • If KIOVIG is administered at a high rate, if you suffer from a condition with low antibody levels in your blood (hypo- or agammaglobulinemia), if you have not received this medicine before or if there has been a long interval (e.g. several weeks) since you last received it, there may be a higher risk of side effects.
Slovenian: • Tveganje za neželene učinke se lahko poveča, če je hitrost infundiranja zdravila KIOVIG velika, če imate motnjo z majhno koncentracijo protiteles v krvi (hipo- ali agamaglobulinemijo) in če tega zdravila še niste prejeli ali ste ga nazadnje prejeli dolgo časa nazaj (npr. pred več tedni).
English: • If dilution is required, 5% glucose solution is recommended.
Slovenian: • Če je potrebno redčenje zdravila, priporočamo 5 % raztopino glukoze.
English: Replacement therapy in adults, and children and adolescents (0-18 years) in:
Slovenian: Nadomestno zdravljenje odraslih ter otrok in mladostnikov (starih od 0 do 18 let) pri naslednjih boleznih in motnjah:
English: If dilution prior to infusion is required, KIOVIG may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin).
Slovenian: Če je pred infundiranjem potrebno redčenje, lahko zdravilo KIOVIG razredčite s 5 % raztopino glukoze do končne koncentracije 50 mg/ml (5 % imunoglobulina).
English: 0.8-1 g/kg or 0.4 g/kg/d on day 1, possibly repeated once within 3 days for 2-5 days
Slovenian: 0,8-1 g/kg ali 0,4 g/kg/d prvi dan, možna ponovitev enkrat v treh dneh za 2-5 dni
English: There is clinical evidence of an association between IVIg administration and thromboembolic events such as myocardial infarction, cerebral vascular accident (including stroke), pulmonary embolism and deep vein thromboses which is assumed to be related to a relative increase in blood viscosity through the high influx of immunoglobulin in at-risk patients.
Slovenian: imunoglobulinov in tromboemboličnimi dogodki, kot so miokardni infarkt, cerebrovaskularni inzult (vključno z možgansko kapjo), pljučna embolija in globoke venske tromboze, ki naj bi bili povezani z relativnim povečanjem viskoznosti krvi zaradi dovajanja velike količine imunoglobulinov pri bolnikih z dejavniki tveganja.
English: The in-use stability of KIOVIG after dilution with a 5% glucose solution to a final concentration of 50 mg/ml (5%) immunoglobulin has been demonstrated for 21 days at 2°C to 8°C as well as 28°C to 30°C; however, these studies did not include the microbial contamination and safety aspect.
Slovenian: Dokazali so, da je po redčenju s 5 % raztopino glukoze do končne koncentracije 50 mg imunoglobulina/ml (5 %) zdravilo KIOVIG med uporabo stabilno 21 dni pri temperaturi od 2°C do 8°C, pa tudi pri temperaturi od 28°C do 30°C, vendar v teh študijah niso upoštevali mikrobne kontaminacije in varnostnega vidika.
English: • KIOVIG should be infused intravenously at an initial rate of 0.5 ml/kg bodyweight/hour for 30 minutes.
Slovenian: • Zdravilo KIOVIG infundirajte intravensko z začetno hitrostjo 0,5 ml/kg TM na uro v času 30 minut.
English: Maintenance dose: 1 g/kg every 2 to 4 weeks or 2 g/kg every 4 to 8 weeks.
Slovenian: Vzdrževalni odmerek: 1 g/kg vsake 2 do 4 tedne ali 2 g/kg vsakih 4 do 8 tednov.
English: If well tolerated, the rate of administration may gradually be increased to a maximum of 6 ml/kg bodyweight/hour.
Slovenian: Če bolnik to dobro prenaša, lahko hitrost infundiranja postopoma povečate do največ 6 ml/kg TM na uro.
English: Instructions for handling and disposal
Slovenian: Navodila za ravnanje z zdravilom in odlaganje:
English: Adequate doses of this medicinal product may restore abnormally low immunoglobulin G levels to the normal range.
Slovenian: Z ustreznimi odmerki zdravila lahko prenizko koncentracijo IgG povečamo do normalnega razpona.
English: KIOVIG 100 mg/ml solution for infusion Human Normal Immunoglobulin Intravenous use.
Slovenian: KIOVIG 100 mg/ml raztopina za infundiranje humani polispecifični imunoglobulin intravenska uporaba
English: Three to six months are required after the initiation of therapy for equilibration (steady-state IgG levels) to occur.
Slovenian: Ravnovesne koncentracije (ravni IgG v stanju dinamičnega ravnovesja) dosežemo po treh do šestih mesecih po začetku zdravljenja.
English: 1.49 1.34 to 1.81 1.67 1.45 to 2.19 1.62 1.50 to 1.78
Slovenian: 1,49 1,34 do 1,81 1,67 1,45 do 2,19 1,62 1,50 do 1,78
English: 0.2-0.4 g/kg every 3-4 weeks to obtain IgG trough level of at least 5-6 g/l
Slovenian: 0,2-0,4 g/kg vsake 3 do 4 tedne, da dosežete najnižjo koncentracijo IgG vsaj 5-6 g/l
English: 2.26 1.70 to 2.60 2.09 1.78 to 2.65 2.17 1.99 to 2.44
Slovenian: 2,26 1,70 do 2,60 2,09 1,78 do 2,65 2,17 1,99 do 2,44
English: 2.28 1.72 to 2.74 2.25 1.98 to 2.64 2.24 1.92 to 2.43
Slovenian: 2,28 1,72 do 2,74 2,25 1,98 do 2,64 2,24 1,92 do 2,43
English: The recommended starting dose is 0.4-0.8 g/kg given once, followed by at least 0.2 g/kg given every three to four weeks.
Slovenian: Priporočeni začetni odmerek je 0,4-0,8 g/kg, kateremu naj sledi najmanj 0,2 g/kg TM vsake tri do štiri tedne.
English: When slowing or stopping the infusion may be required
Slovenian: Kdaj je lahko potrebno počasnejše intravensko infundiranje ali prekinitev infundiranja
English: Therefore patients receiving measles vaccine should have their antibody status checked.
Slovenian: Zato morate pri bolnikih, ki bodo dobili cepivo proti ošpicam, preveriti količino protiteles v krvi.
English: Adverse reactions such as chills, headache, dizziness, fever, vomiting, allergic reactions, nausea, arthralgia, low blood pressure and moderate low back pain may occur occasionally.
Slovenian: Lahko se občasno pojavijo neželeni učinki, npr. mrzlica, glavobol, omotica, zvišana telesna temperatura, bruhanje, alergijske reakcije, navzea, artralgija, nizek krvni tlak in zmerna bolečina v ledvenem predelu hrbta.
English: If dilution is required, 5% glucose solution is recommended.
Slovenian: Če je potrebno redčenje zdravila, priporočamo 5 % raztopino glukoze.
English: In these rare cases, you may get allergic reactions such as a sudden fall in blood pressure or shock even if you have already received treatment with medicines containing antibodies in the past.
Slovenian: To se lahko zgodi zlasti, če imate pomanjkanje imunoglobulina A. V teh redkih primerih se lahko pri vas razvije alergijska reakcija v obliki nenadnega zmanjšanja krvnega tlaka ali šoka, celo če ste se že zdravili z zdravili, ki vsebujejo protitelesa.
English: Dose recommendations
Slovenian: Priporočila za odmerke
English: Contusion, pruritus, urticaria, dermatitis, erythema Common Angioedema, acute urticaria, cold sweat, photosensitivity reaction, night sweats, hyperhidrosis
Slovenian: Bolezni kože in podkožja izpuščaj zelo pogosti kontuzija, srbenje, urtikarija, dermatitis, eritem pogosti angioedem, akutna urtikarija, hladen pot, fotosenzitivnostna reakcija, nočno potenje, hiperhidroza občasni
English: Blood cholesterol increased, blood creatinine increased, blood urea increased, white blood cell count decreased, alanine aminotransferase increased, haematocrit decreased, red blood cell count decreased, respiratory rate increased
Slovenian: Preiskave zvišana koncentracija holesterola v krvi, zvišana koncentracija kreatinina v krvi, zvišana koncentracija sečnine v krvi, znižano število levkocitov, zvišana vrednost alanin-aminotransferaze, znižan hematokrit, znižano število eritrocitov, zvišana frekvenca dihanja občasni
English: 20 g / 200 ml
Slovenian: 20 g v 200 ml
English: Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of live attenuated virus vaccines such as measles, rubella, mumps and varicella.
Slovenian: Uporaba imunoglobulinov lahko zmanjša učinkovitost cepiv z živimi oslabljenimi virusi, kot so cepiva proti ošpicam, rdečkam, mumpsu in noricam, za najmanj 6 tednov in do 3 mesece.
English: • Keep the container in the outer carton in order to protect from light.
Slovenian: • Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
English: Cases of reversible aseptic meningitis and rare cases of transient cutaneous reactions (including cutaneous lupus erythematosus - frequency unknown) have been observed with human normal immunoglobulin.
Slovenian: Pri uporabi humanih polispecifičnih immunoglobulinov so opažali primere reverzibilnega aseptičnega meningitisa in redke primere prehodnih kožnih reakcij (vključno s kožnim eritematoznim lupusompogostnost neznana).
English: Hypotension, deep vein thrombosis
Slovenian: Žilne bolezni hipotenzija, globoka venska tromboza neznani
English: The same indications, dose and frequency of infusion as for adults apply for children and adolescents (age 0 to 18).
Slovenian: Za otroke in mladostnike (0-18 let) veljajo enake indikacije, odmerki in pogostnosti infundiranja kot za odrasle.
English: The solution should be clear or slightly opalescent and colourless or pale yellow.
Slovenian: Raztopina mora biti bistra ali rahlo opalescentna in brezbarvna do bledo rumena.
English: Chronic sinusitis, fungal infection, infection, kidney infection, sinusitis, upper respiratory tract infection, urinary tract infection, bacterial urinary tract infection, meningitis aseptic
Slovenian: Infekcijske in parazitske bolezni bronhitis, nazofaringitis pogosti kronični sinusitis, glivična okužba, okužba, ledvična okužba, sinusitis, okužba zgornjih dihalnih poti, okužba sečil, bakterijska okužba sečil, aseptični meningitis občasni
English: 30 g / 300 ml
Slovenian: 30 g v 300 ml
English: Talk to your doctor, pharmacist or nurse before using KIOVIG.
Slovenian: Pred začetkom uporabe zdravila KIOVIG se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: Immune system disorders Hypersensitivity, anaphylactic reaction
Slovenian: Bolezni imunskega sistema preobčutljivost, anafilaktična reakcija občasni
English: Chronic infection of the nose, fungal infections, various infections (of the nose and throat, kidney or bladder), sterile inflammation of the layers lining the brain, serious allergic reactions, disorder of the thyroid, excessive response to stimuli, memory impairment, difficulty in speaking, unusual taste in the mouth, impaired balance, involuntary trembling, eye pain or swelling, vertigo, fluid in middle ear, peripheral coldness, vein inflammation, ear and throat swelling, abdominal distension, rapid swelling of the skin, acute inflammation of the skin, cold sweat, increased reaction of the skin to sunlight, excessive sweating also during sleep, muscle twitching, excess of serum protein in the urine, chest tightness, feeling hot, burning sensation, swelling, increased rate of breathing, changes to blood test results.
Slovenian: • Občasni neželeni učinki (lahko se pojavijo pri največ 1 od 100 bolnikov): kronične okužbe nosu, glivične okužbe, razne okužbe (nosu in žrela, ledvic ali sečnega mehurja), sterilno vnetje možganskih ovojnic, resne alergijske reakcije, bolezen ščitnice, čezmeren odziv na dražljaje, motnje spomina, otežen govor, nenavaden okus v ustih, motnje ravnotežja, nehotna tresavica, bolečine v očesu ali otekanje očesa, vrtoglavica, tekočina v srednjem ušesu, hladne dlani in stopala, vnetje ven, otekanje ušes in grla, napihnjen trebuh, hitro otekanje kože, akutno vnetje kože, hladen pot, večja reakcija kože na sončno svetlobo, čezmerno potenje tudi med spanjem, trzanje mišic, prevelika količina serumskih beljakovin v urinu, tiščanje v prsih, navali vročine, pekoč občutek, otekanje, pospešeno dihanje, spremembe izvidov krvnih preiskav.
English: It is distributed relatively rapidly between plasma and extravascular fluid; after approximately 3 to 5 days equilibrium is reached between the intra- and extravascular compartments.
Slovenian: Ravnovesje med znotrajžilnim in zunajžilnim razdelkom se vzpostavi po približno 3 do 5 dneh.
English: If you use more KIOVIG than you should
Slovenian: Če ste prejeli večji odmerek zdravila KIOVIG, kot bi smeli
English: Discontinuation of IVIg treatment has resulted in remission of AMS within several days without sequelae.
Slovenian: imunoglobulini prekine, po več dneh pride do remisije AMS brez posledic.
English: Immune system disorders Anaphylactic shock
Slovenian: Bolezni imunskega sistema anafilaktični šok neznani
English: In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped.
Slovenian: V primeru neželenih učinkov morate bodisi zmanjšati hitrost infundiranja ali infundiranje prekiniti.
English: Frequency of injections
Slovenian: Pogostnost odmerjanja
English: Bronchitis, common cold, low red blood cell count, swollen lymph glands, decreased appetite, difficulty in sleeping, anxiety, dizziness, migraine, numbness or tingling of the skin or of a limb, reduced sense of touch, eye inflammation, rapid heartbeat, flushing, cough, runny nose, chronic cough or wheezing (asthma), stuffy nose, sore throat, shortness of breath, diarrhoea, vomiting, abdominal pain, indigestion, contusion, itchingand hives, dermatitis, reddened skin, pain in your back, pain in your joints, pain in your arms or legs, muscle pain, muscle cramps, muscular weakness, chills, accumulation of fluid under the skin, influenza-like illness, pain or discomfort in the chest, lack of strength or feeling of weakness, indisposition, shaking chills.
Slovenian: • Pogosti neželeni učinki (lahko se pojavijo pri največ 1 od 10 bolnikov): bronhitis, prehlad, majhno število rdečih krvnih celic, otekle bezgavke, zmanjšan apetit, motnje spanca, tesnoba, omotica, migrena, odrevenelost ali mravljinčenje po koži ali v udih, zmanjšana občutljivost za dotik, vnetje očesa, pospešen srčni utrip, pordelost, kašelj, izcedek iz nosu, kroničen kašelj ali sopenje (astma), zamašen nos, vnetje žrela, zasoplost, driska, bruhanje, trebušne bolečine, motnje prebave, obtolčenine, srbenje in koprivnica, dermatitis, pordela koža, bolečine v hrbtu, bolečine v sklepih, bolečine v rokah ali nogah, bolečine v mišicah, krči v mišicah, mišična šibkost, mrazenje, kopičenje tekočine pod kožo, gripi podobni simptomi, bolečine ali neugodje v prsnem košu, nemoč ali občutek šibkosti, slabo počutje, drgetanje.
English: Do not use if particulate matter or discolouration is observed.
Slovenian: Zdravila ne uporabljajte, če opazite v njem delce ali če je raztopina obarvana.
English: • KIOVIG should be inspected visually for particulate matter and discoloration prior to administration.
Slovenian: • Zdravilo KIOVIG morate pred uporabo vizualno pregledati, ali morda vsebuje delce in ali je obarvano.
English: KIOVIG 100 mg/ml solution for infusion Human normal immunoglobulin
Slovenian: KIOVIG 100 mg/ml raztopina za infundiranje humani polispecifični imunoglobulin
English: Blood and lymphatic system disorders
Slovenian: Bolezni krvi in limfatičnega sistema hemoliza neznani
English: Since KIOVIG contains trace amounts of immunoglobulin A (less than 0.14 mg/ml), you might get an allergic reaction.
Slovenian: Če imate na primer pomanjkanje imunoglobulina A, imate lahko v krvi protitelesa proti imunoglobulinu A. Ker zdravilo KIOVIG vsebuje imunoglobulin A v sledovih (do 0,14 mg/ml), lahko to pri vas povzroči alergijsko reakcijo.
English: There is reassuring clinical experience regarding the lack of hepatitis A or Parvovirus B19 transmission with immunoglobulins and it is also assumed that the antibody content makes an important contribution to the viral safety.
Slovenian: Obstajajo pomirjujoče klinične izkušnje o tem, da se virus hepatitisa A in parvovirus B19 ne prenašata z imunoglobulini.
English: 5 g / 50 ml
Slovenian: 5 g v 50 ml
English: Keep the container in the outer carton in order to protect from light.
Slovenian: Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
English: Any infusion-related adverse events should be treated by lowering infusion rates or by stopping the infusion.
Slovenian: Vse morebitne neželene učinke, povezane z infuzijo, odpravite z zmanjšanjem hitrosti infundiranja ali z ustavitvijo infuzije.
English: Destruction of red blood cells, life-threatening allergic shock, transient stroke, stroke, low blood pressure, heart attack, blood clot in a major vein, blood clot in the main artery of the lung, accumulation of fluid in the lung, positive result of Coombs test, decreased oxygen saturation in blood, transfusion-related acute lung injury.
Slovenian: • Neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov): razgradnja rdečih krvnih celic, življenjsko ogrožajoči alergijski šok, prehodna možganska kap, možganska kap, nizek krvni tlak, srčni infarkt, krvni strdek v veliki veni, krvni strdek v glavni pljučni arteriji, kopičenje tekočine v pljučih, pozitiven rezultat Coombsovega testa, zmanjšana nasičenost krvi s kisikom, s transfuzijo povezana akutna poškodba pljuč.
English: A transient decrease in neutrophil count and/or episodes of neutropenia, sometimes severe, have been reported after treatment with IVIgs.
Slovenian: imunoglobulini so poročali o prehodnem zmanjšanju števila nevtrofilcev in/ali nevtropeničnih epizodah, včasih hudih.
English: KIOVIG is a solution for infusion in vials of 10, 25, 50, 100, 200 or 300 ml.
Slovenian: Zdravilo KIOVIG je raztopina za infundiranje v vialah po 10, 25, 50, 100, 200 ali 300 ml. Raztopina je bistra ali rahlo opalescentna in brezbarvna ali bledo rumena.
English: • Any infusion-related adverse events should be treated by lowering infusion rates or by stopping the infusion.
Slovenian: • Vse morebitne neželene učinke, povezane z infuzijo, zdravite z zmanjšanjem hitrosti infundiranja ali z ustavitvijo infuzije.
English: Hyperproteinemia, increased serum viscosity and subsequent relative pseudohyponatremia may occur in patients receiving IVIg therapy.
Slovenian: imunoglobuline, se lahko pojavi hiperproteinemija, zvišana viskoznost seruma in posledična psevdohiponatriemija.
English: KIOVIG should only be administered intravenously.
Slovenian: Zdravilo KIOVIG je namenjeno samo za intravensko uporabo.
English: This typically occurs within hours or days after IVIg administration and resolves spontaneously within 7 to 14 days.
Slovenian: imunoglobulinov in spontano mine v 7 do 14 dneh.
English: 0.2-0.4 g/kg every 3-4 weeks to obtain IgG trough level above 5g/l
Slovenian: 0,2-0,4 g/kg vsake 3 do 4 tedne, da dosežete najnižjo koncentracijo IgG vsaj 5 g/l
English: Chest tightness, feeling hot, burning sensation, swelling
Slovenian: Pediatrična populacija tiščanje v prsih, navali vročine, pekoč občutek, otekanje občasni
English: Solution for infusion The solution is clear or slightly opalescent and colourless or pale yellow.
Slovenian: Raztopina za intravensko infundiranje Raztopina je bistra ali rahlo opalescentna in brezbarvna ali bledorumena.
English: What KIOVIG contains
Slovenian: Kaj vsebuje zdravilo KIOVIG
English: Nervous system disorders Headache
Slovenian: Srčne bolezni miokardni infarkt neznani
English: In patients receiving IVIg, there have been reports of acute non-cardiogenic pulmonary edema (Transfusion Related Acute Lung Injury, (TRALI) in patients administered IVIg (including KIOVIG).
Slovenian: imunoglobuline (vključno z zdravilom KIOVIG), so poročali o akutnem nekardiogenem pljučnem edemu (s transfuzijo povezani akutni poškodbi pljuč, TRALI).
English: Starting dose: 2 g/kg divided over 2 -5 consecutive days
Slovenian: Začetni odmerek: 2 g/kg v obdobju 2-5 zaporednih dni
English: 2 g/kg should be administered as a single dose.
Slovenian: Odmerek 2 g/kg dajajte v enkratnem odmerku.
English: Haemolysis
Slovenian: Odmerek
English: starting dose: 2 g/kg maintenance dose: 1 g/kg or 2 g/kg given over 2-5 days every 2-4 weeks or every 4-8 weeks over 2-5 days d = day
Slovenian: začetni odmerek: 2 g/kg vzdrževalni odmerek: 1 g/kg oz. 2 g/kg dan v času 2-5 dni vsake 2 do 4 tedne oz. vsakih 4 do 8 tednov v obdobju 25 dni
English: 10 g / 100 ml
Slovenian: 10 g v 100 ml
English: Diarrhoea, vomiting, abdominal pain, dyspepsia
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora pljučna embolija, pljučni edem neznani
English: Anaphylaxis can develop in patients
Slovenian: Anafilaksa se lahko pojavi pri bolnikih:
English: • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Slovenian: • Kronična vnetna demielinizacijska poliradikulonevropatija (CIPD).
English: Starting dose: 2 g/kg given over 2-5 consecutive days.
Slovenian: Začetni odmerek: 2 g/kg, dan v času 2-5 zaporednih dni.
English: Patients who suffer from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Slovenian: Bolniki s kronično vnetno demielinizacijsko poliradikulonevropatijo (CIPD).
English: Amnesia, dysarthria, dysgeusia, balance disorder, tremor
Slovenian: Bolezni živčevja glavobol zelo pogosti omotica, migrena, parestezija, hipoestezija pogosti amnezija, disartrija, disgevzija, motnje ravnotežja, tremor občasni
English: Decreased appetite
Slovenian: Presnovne in prehranske motnje zmanjšan apetit pogosti
English: Aseptic meningitis syndrome has been reported to occur in association with IVIg treatment.
Slovenian: imunoglobulini so opisali pojav sindroma aseptičnega meningitisa.
English: Back pain, arthralgia, pain in extremity, myalgia, muscle spasms, muscular weakness
Slovenian: Bolezni kosti, sklepov, mišic in vezivnega tkiva bolečine v hrbtu, artralgija, bolečine v udih, mialgija, mišični krči, mišična šibkost pogosti trzanje mišic občasni
English: Chronic inflammatory demyelinating polyneuropathy (CIDP)
Slovenian: Kronična vnetna demielinizacijska polinevropatija (CIPD)
English: How to store KIOVIG
Slovenian: Shranjevanje zdravila KIOVIG
English: The product should be inspected visually for particulate matter and discolouration prior to administration.
Slovenian: Zdravilo morate pred uporabo vizualno pregledati, ali morda vsebuje delce in ali je obarvano.